Effects of the physical form of diet on growth performance, ascites and sudden death syndrome incidences in broiler chickens

ΔΕΝ ΔΙΑΤΙΘΕΤΑΙ ΠΕΡΙΛΗΨΗThis experiment was conducted to determine the effects of the diet physical form, Mash (M), Pellet (P) and Extruded (E) on the growth performance, carcass characteristics and metabolic disorders ascites (AS) and as well as sudden death syndrome (SDS) in the broiler chickens. In this respect, feed intake (FI), weight gain (WG) and mortalitywere recorded throughout the experiment and biochemical parameters, hematology and carcass characteristics were tested at 35 and 42 days of age respectively. The results showed that with the increase of the average daily weight gain (ADWG) (p<0.01), the relative breast weight to the carcass weight (p<0.05), better feed conversion ratio (p<0.01), the lower relative cecum weight and gizzard to the carcass weight (p<0.05) were observed by applying the E diet form, as compared with the other treatments. A significant increase in the average daily feed intake (ADFI) was also observed by using the P diet form (p<0.01). Hematological parameters including hemoglobin (Hb), hematocrit (HCT), urea, uric acid, triglyceride, the ratio of low-density lipoprotein to high-density lipoprotein (LDL/HDL), very low-density lipoprotein (VLDL), enzyme activities of aspartate aminotransferase(AST) and alanine aminotransferase (ALT) of the blood serum were lowered by applying the M treatment, as compared with the other treatments (p<0.05). The results indicated that the performance and carcass characteristics were improved by the E and P diet forms; also, with raising the hematology parameters in these treatments, the mortality of ascites and SDS was increased

Repositioning of the global epicentre of non-optimal cholesterol

High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.</p

Repositioning of the global epicentre of non-optimal cholesterol

High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol�which is a marker of cardiovascular risk�changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95 credible interval 3.7 million�4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world. © 2020, The Author(s), under exclusive licence to Springer Nature Limited

Effect of Vitamin C on Performance, Egg Characteristics and Some Blood Parameters of Laying Hens

This experiment was conducted to evaluate the effects of vitamin C on laying hens performance, egg characteristics and some blood parameters under normal rearing condition. One hundred and ninety two 24 - weeks - old laying hens diet were used in a completely randomized design with 4 treatments (0, 250, 500 and 750 mg vitamin C/kg diet) and 4 replicates for 105 days. Although feed consumption, feed conversion ratio and hen–day egg production were similar among treatments (P>0.05), final body weight was significantly increased (